Search results
Results from the WOW.Com Content Network
It is an official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. [3] The journal is published monthly and includes original research on all areas of osteoporosis and its related fields, alongside reviews, educational articles, and case reports. The co-editors-in-chief are J.A. Kanis and F. Cosman.
The Royal Osteoporosis Society supports ground-breaking and pioneering research aimed at improving the prevention, diagnosis treatment of osteoporosis. The charity has invested over £5 million in more than 130 projects which have enhanced knowledge and understanding of osteoporosis, leading to significant improvements in diagnosis and treatment.
A new draft recommendation from the U.S. Task Force says taking vitamin D supplements with or without calcium does not prevent falls or fractures in older adults. kali9/Getty Images
Archives of Osteoporosis is a peer-reviewed medical journal published by Springer Science+Business Media. [1] It was established in 2006 and is an official journal of the International Osteoporosis Foundation and the United States' National Osteoporosis Foundation . [ 1 ]
Some women lose up to 25% of bone mass in the first 10 years after menopause. Have a small, thin body (weigh less than 127 pounds) Have a family history of osteoporosis. Are Mexican-American or white.
The US National Osteoporosis Foundation recommends pharmacologic treatment for patients with hip or spine fracture thought to be related to osteoporosis, those with BMD 2.5 SD or more below the young normal mean (T-score -2.5 or below), and those with BMD between 1 and 2.5 SD below normal mean whose 10-year risk, using FRAX, for hip fracture is ...
The International Osteoporosis Foundation organises the annual World Osteoporosis Day, observed internationally on October 20. [10] The day is dedicated to raising global awareness of the prevention, diagnosis and treatment of osteoporosis and related diseases of bones, muscles and joints. [11] [12]
Romosozumab is used for osteoporosis to decrease the risk of fractures. [10] Two trials found that it reduced the rate of vertebral fracture. In one, there was a 73% lower risk of vertebral fracture after one year, and the benefit was maintained after a second year of taking denosumab.